Prevalence and risk factors for pulmonary arterial hypertension in end-stage renal disease patients undergoing continuous ambulatory peritoneal dialysis

References

• Levey AS, Coresh J. Chronic kidney disease. Lancet. 2012;379:165–180
   PubMed Web of Science ®Google Scholar
• GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117–171
   PubMed Web of Science ®Google Scholar
• Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med. 2003;139:137–147
   PubMed Web of Science ®Google Scholar
• Fox CS, Matsushita K, Woodward M, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: A meta-analysis. Lancet. 2012;380:1662–1673
   PubMed Web of Science ®Google Scholar
• Levey AS, Becker C, Inker LA. Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: A systematic review. JAMA. 2015;313:837–846
   PubMed Web of Science ®Google Scholar
• Heidenheim AP, Kooistra MP, Lindsay RM. Quality of life. Contrib Nephrol. 2004;145:99–105
   PubMed Web of Science ®Google Scholar
• Yong DS, Kwok AO, Wong DM, et al. Symptom burden and quality of life in end-stage renal disease: A study of 179 patients on dialysis and palliative care. Palliat Med. 2009;23:111–119
   PubMed Web of Science ®Google Scholar
• Villar E, McDonald SP, Couchoud C. Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline: Response to Burrows, Li, and Geiss. Diabetes Care. 2010;33:e69 (author reply e70)
   Google Scholar
• Sanabria M, Muñoz J, Trillos C, et al. Dialysis outcomes in Colombia (DOC) study: A comparison of patient survival on peritoneal dialysis vs hemodialysis in Colombia. Kidney Int Suppl. 2008;108:S165–S172
   PubMed Web of Science ®Google Scholar
• Mehrotra R, Chiu YW, Kalantar-Zadeh K, et al. Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch Intern Med. 2011;171:110–118
   PubMed Web of Science ®Google Scholar
• Rufino JM, García C, Vega N, et al. [Current peritoneal dialysis compared with hemodialysis: Medium-term survival analysis of incident dialysis patients in the Canary Islands in recent years]. Nefrologia. 2011;31:174–184
   PubMed Web of Science ®Google Scholar
• Crowe E, Halpin D, Stevens P, Guideline Development Group. Early identification and management of chronic kidney disease: Summary of NICE guidance. BMJ. 2008;337:a1530
   PubMed Web of Science ®Google Scholar
• Abdelwhab S, Elshinnawy S. Pulmonary hypertension in chronic renal failure patients. Am J Nephrol. 2008;28:990–997
   PubMed Web of Science ®Google Scholar
• Alhamad EH, Al-Ghonaim M, Alfaleh HF, et al. Pulmonary hypertension in end-stage renal disease and post renal transplantation patients. J Thorac Dis. 2014;6:606–616
   PubMed Web of Science ®Google Scholar
• Hoeper MM. Definition, classification, and epidemiology of pulmonary arterial hypertension. Semin Respir Crit Care Med. 2009;30:369–375
   PubMed Web of Science ®Google Scholar
• Montani D, Günther S, Dorfmüller P, et al. Pulmonary arterial hypertension. Orphanet J Rare Dis. 2013;8:97
   PubMed Web of Science ®Google Scholar
• Zhao LJ, Huang SM, Liang T, Tang H. Pulmonary hypertension and right ventricular dysfunction in hemodialysis patients. Eur Rev Med Pharmacol Sci. 2014;18:3267–3273
   PubMed Web of Science ®Google Scholar
• Sise ME, Courtwright AM, Channick RN. Pulmonary hypertension in patients with chronic and end-stage kidney disease. Kidney Int. 2013;84:682–692
   PubMed Web of Science ®Google Scholar
• Agarwal R. Prevalence, determinants and prognosis of pulmonary hypertension among hemodialysis patients. Nephrol Dial Transplant. 2012;27:3908–3914
   PubMed Web of Science ®Google Scholar
• Ramasubbu K, Deswal A, Herdejurgen C, et al. A prospective echocardiographic evaluation of pulmonary hypertension in chronic hemodialysis patients in the United States: Prevalence and clinical significance. Int J Gen Med. 2010;3:279–286
   PubMedGoogle Scholar
• Li Z, Liang X, Liu S, et al. Pulmonary hypertension: Epidemiology in different CKD stages and its association with cardiovascular morbidity. PLoS One. 2014;9:e114392
   PubMed Web of Science ®Google Scholar
• Glas J, Seiderer J, Bues S, et al. IRGM variants and susceptibility to inflammatory bowel disease in the German population. PLoS One. 2013;8:e54338
   PubMed Web of Science ®Google Scholar
• Mansour IN, Lang RM, Aburuwaida WM, et al. Evaluation of the clinical application of the ACCF/ASE appropriateness criteria for stress echocardiography. J Am Soc Echocardiogr. 2010;23:1199–1204
   PubMed Web of Science ®Google Scholar
• Kosmadakis G, Aguilera D, Carceles O, et al. Pulmonary hypertension in dialysis patients. Ren Fail. 2013;35:514–520
   PubMed Web of Science ®Google Scholar
• Etemadi J, Zolfaghari H, Firoozi R, et al. Unexplained pulmonary hypertension in peritoneal dialysis and hemodialysis patients. Rev Port Pneumol. 2012;18:10–14
   PubMed Web of Science ®Google Scholar
• Oygar DD, Zekican G. Pulmonary hypertension in dialysis patients. Ren Fail. 2012;34:840–844
   PubMed Web of Science ®Google Scholar
• Nasri H. Unexplained pulmonary hypertension in peritoneal dialysis and hemodialysis patients. Rev Port Pneumol. 2013;19:238–239
   PubMed Web of Science ®Google Scholar
• Cho KH, Do JY, Park JW, Yoon KW. Effect of icodextrin dialysis solution on body weight and fat accumulation over time in CAPD patients. Nephrol Dial Transplant. 2010;25:593–599
   PubMed Web of Science ®Google Scholar
• Stuart S, Booth TC, Cash CJ, et al. Complications of continuous ambulatory peritoneal dialysis. Radiographics. 2009;29:441–460
   PubMed Web of Science ®Google Scholar
• Zanger R. Hyponatremia and hypokalemia in patients on peritoneal dialysis. Semin Dial. 2010;23:575–580
   PubMed Web of Science ®Google Scholar
• Bots CP, Brand HS, Veerman EC, et al. Interdialytic weight gain in patients on hemodialysis is associated with dry mouth and thirst. Kidney Int. 2004;66:1662–1668
   PubMed Web of Science ®Google Scholar
• Bruzda-Zwiech A, Szczepańska J, Zwiech R. Sodium gradient, xerostomia, thirst and inter-dialytic excessive weight gain: A possible relationship with hyposalivation in patients on maintenance hemodialysis. Int Urol Nephrol. 2014;46:1411–1417
   PubMed Web of Science ®Google Scholar
• López-Gómez JM, Villaverde M, Jofre R, et al. Interdialytic weight gain as a marker of blood pressure, nutrition, and survival in hemodialysis patients. Kidney Int Suppl. 2005;93:S63–S68
   PubMed Web of Science ®Google Scholar
• Hecking M, Karaboyas A, Saran R, et al. Dialysate sodium concentration and the association with interdialytic weight gain, hospitalization, and mortality. Clin J Am Soc Nephrol. 2012;7:92–100
   PubMed Web of Science ®Google Scholar
• Fabbian F, Cantelli S, Molino C, et al. Pulmonary hypertension in dialysis patients: A cross-sectional Italian study. Int J Nephrol. 2011;2011:283475
   Google Scholar
• Pyxaras SA, Pinamonti B, Barbati G, et al. Echocardiographic evaluation of systolic and mean pulmonary artery pressure in the follow-up of patients with pulmonary hypertension. Eur J Echocardiogr. 2011;12:696–701
   PubMedGoogle Scholar
• Chemla D, Humbert M, Sitbon O, et al. Systolic and mean pulmonary artery pressures: Are they interchangeable in patients with pulmonary hypertension? Chest. 2015;147:943–950
   PubMed Web of Science ®Google Scholar
• Kannel WB. Elevated systolic blood pressure as a cardiovascular risk factor. Am J Cardiol. 2000;85:251–255
   PubMed Web of Science ®Google Scholar
• Glynn RJ, L'Italien GJ, Sesso HD, et al. Development of predictive models for long-term cardiovascular risk associated with systolic and diastolic blood pressure. Hypertension. 2002;39:105–110
   PubMed Web of Science ®Google Scholar
• Gottdiener JS, Panza JA, St John Sutton M, et al. Testing the test: The reliability of echocardiography in the sequential assessment of valvular regurgitation. Am Heart J. 2002;144:115–121
   PubMed Web of Science ®Google Scholar
• Unal A, Sipahioglu M, Oguz F, et al. Pulmonary hypertension in peritoneal dialysis patients: Prevalence and risk factors. Perit Dial Int. 2009;29:191–198
   PubMed Web of Science ®Google Scholar
• Mahajan A, Simoni J, Sheather SJ, et al. Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy. Kidney Int. 2010;78:303–309
   PubMed Web of Science ®Google Scholar
• Hart PD, Bakris GL. Hypertensive nephropathy: Prevention and treatment recommendations. Expert Opin Pharmacother. 2010;11:2675–2686
   PubMed Web of Science ®Google Scholar
• Foris V, Kovacs G, Tscherner M, et al. Biomarkers in pulmonary hypertension: What do we know? Chest. 2013;144:274–283
   PubMed Web of Science ®Google Scholar
• Kwon YS, Chi SY, Shin HJ, et al. Plasma C-reactive protein and endothelin-1 level in patients with chronic obstructive pulmonary disease and pulmonary hypertension. J Korean Med Sci. 2010;25:1487–1491
   PubMed Web of Science ®Google Scholar
• Scognamiglio G, Kempny A, Price LC, et al. Creactive protein in adults with pulmonary arterial hypertension associated with congenital heart disease and its prognostic value. Heart. 2014;100:1335–1341
   PubMed Web of Science ®Google Scholar
• Frantz RP, McDevitt S, Walker S. Baseline NT-proBNP correlates with change in 6-minute walk distance in patients with pulmonary arterial hypertension in the pivotal inhaled treprostinil study TRIUMPH-1. J Heart Lung Transplant. 2012;31:811–816
   PubMed Web of Science ®Google Scholar
• Soon E, Doughty NJ, Treacy CM, et al. Log-transformation improves the prognostic value of serial NT-proBNP levels in apparently stable pulmonary arterial hypertension. Pulm Circ. 2011;1:244–249
   PubMedGoogle Scholar
• Obineche EN, Pathan JY, Fisher S, et al. Natriuretic peptide and adrenomedullin levels in chronic renal failure and effects of peritoneal dialysis. Kidney Int. 2006;69:152–156
   PubMed Web of Science ®Google Scholar
• David S, Kümpers P, Seidler V, et al. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on hemodialysis. Nephrol Dial Transplant. 2008;23:1370–1377
   PubMed Web of Science ®Google Scholar
• K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;45:S1–S153
   Web of Science ®Google Scholar
• London GM, Pannier B, Guerin AP, et al. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: Follow-up of an interventional study. J Am Soc Nephrol. 2001;12:2759–2767
   PubMed Web of Science ®Google Scholar
• Wang AY, Wang M, Woo J, et al. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: A prospective study. J Am Soc Nephrol. 2003;14:159–168
   PubMed Web of Science ®Google Scholar
• Wang AY. Vascular and valvular calcification in chronic peritoneal dialysis patients. Int J Nephrol. 2011;2011:Article ID 198045
   Google Scholar
• Agarwal R, Shah SJ, Foreman AJ, et al. Risk assessment in pulmonary hypertension associated with heart failure and preserved ejection fraction. J Heart Lung Transplant. 2012;31:467–477
   PubMed Web of Science ®Google Scholar
• Adir Y, Amir O. Pulmonary hypertension associated with left heart disease. Semin Respir Crit Care Med. 2013;34:665–680
   PubMed Web of Science ®Google Scholar
• Mathai SC, Sibley CT, Forfia PR, et al. Tricuspid annular plane systolic excursion is a robust outcome measure in systemic sclerosis-associated pulmonary arterial hypertension. J Rheumatol. 2011;38:2410–2418
   PubMed Web of Science ®Google Scholar
• De Sutter J, De Backer J, Van de Veire N, et al. Effects of age, gender, and left ventricular mass on septal mitral annulus velocity (E') and the ratio of transmitral early peak velocity to E' (E/E'). Am J Cardiol. 2005;95:1020–1023
   PubMed Web of Science ®Google Scholar
• Kumbar L, Fein PA, Rafiq MA, et al. Pulmonary hypertension in peritoneal dialysis patients. Adv Perit Dial. 2007;23:127–131
   PubMedGoogle Scholar
• Piao L, Fang YH, Parikh KS, et al. GRK2-mediated inhibition of adrenergic and dopaminergic signaling in right ventricular hypertrophy: Therapeutic implications in pulmonary hypertension. Circulation. 2012;126:2859–2869
   PubMed Web of Science ®Google Scholar